Health
Rheumatoid Arthritis Drug Baricitinib Linked to Reduced Mortality in COVID-19 Patients – Cath Lab Digest
November 13, 2020 — The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according…
November 13, 2020 The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research by an international team coordinated by researchers from Karolinska Institutet in Sweden. The findings, published in the journal Science Advances, support the continuation of ongoing randomized clinical trials.
We are pleased to report a 71 percent reduction in mortality for the group receiving baricitinib in addition…
-
Noosa News21 hours agoGrieving Queensland mother demands answers over ‘suspicious’ Bali death of 23-year-old Byron Haddow
-
Noosa News17 hours agoCharacter design compromises in new sets cause controversy among adults
-
Noosa News24 hours agoQueensland government unveils long-term tourism strategy Destination 2045
-
General19 hours agoCan Gap Inc.’s Richard Dickson bring back Banana Republic’s relevancy in retail?